Tag Archives: tocilizumab

Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study

Well timed therapy with tocilizumab possible to enhance medical outcomes in extreme COVID-19 sufferers, finds research Sufferers with extreme COVID-19 are more likely to have short-term mortality charges (loss of life earlier than 90 days of hospitalisation) between 35 p.c to 62 p.c, in keeping with a research revealed within the journal JAMA Inner Medication. With… Read More »